Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma

por Younossi, Zobair M., Henry, Linda
Publicado 2021

Pediatric Non-Alcoholic Fatty Liver Disease

por Bush, Haley, Golabi, Pegah, Younossi, Zobair M.
Publicado 2017

Nonalcoholic steatohepatitis: global impact and clinical consequences

por Kabarra, Khaled, Golabi, Pegah, Younossi, Zobair M
Publicado 2021

Non-Invasive markers for hepatic fibrosis

por Baranova, Ancha, Lal, Priyanka, Birerdinc, Aybike, Younossi , Zobair M
Publicado 2011

Exercise as an intervention for patients with end-stage liver disease: Systematic review

por Locklear, Cameron T., Golabi, Pegah, Gerber, Lynn, Younossi, Zobair M.
Publicado 2018

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis

por Sayiner, Mehmet, Lam, Brian, Golabi, Pegah, Younossi, Zobair M.
Publicado 2018

Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC

por Younossi, Zobair M., Stepanova, Maria, Younossi, Issah, Racila, Andrei
Publicado 2023

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

por Younossi, Zobair M, Zheng, Li, Stepanova, Maria, Venkatesan, Chapy, Mishra, Alita
Publicado 2014

Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population

por Arshad, Tamoore, Golabi, Pegah, Paik, James, Mishra, Alita, Younossi, Zobair M.
Publicado 2018

Importance of fatigue and its measurement in chronic liver disease

por Gerber, Lynn H, Weinstein, Ali A, Mehta, Rohini, Younossi, Zobair M
Publicado 2019

It is time to expand the fatty liver disease community of practice

por Lazarus, Jeffrey V., Kopka, Christopher J., Younossi, Zobair M., Allen, Alina M.
Publicado 2023

Impact of healthcare reform on the payer mix among young adult emergency department utilizers across the United States (2005–2015)

por Bush, Haley, Gerber, Lynn H., Stepanova, Maria, Escheik, Carey, Younossi, Zobair M.
Publicado 2018

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin

por Younossi, Zobair M, Birerdinc, Aybike, Estep, Mike, Stepanova, Maria, Afendy, Arian, Baranova, Ancha
Publicado 2012

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)

por Birerdinc, Aybike, Afendy, Arian, Stepanova, Maria, Younossi, Issah, Baranova, Ancha, Younossi, Zobair M
Publicado 2012

Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects

por Mehta, Rohini, Neupane, Arpan, Wang, Lei, Goodman, Zachary, Baranova, Ancha, Younossi, Zobair M
Publicado 2014

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens

por Younossi, Zobair M., Stepanova, Maria, Henry, Linda, Nader, Fatema, Younossi, Youssef, Hunt, Sharon
Publicado 2016

Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease

por Sayiner, Mehmet, Stepanova, Maria, Pham, Huong, Noor, Bashir, Walters, Mercedes, Younossi, Zobair M
Publicado 2016

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

por Golabi, Pegah, Fazel, Sofie, Otgonsuren, Munkhzul, Sayiner, Mehmet, Locklear, Cameron T., Younossi, Zobair M.
Publicado 2017

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir

por Younossi, Zobair M., Stepanova, Maria, Omata, Masao, Mizokami, Masashi, Walters, Mercedes, Hunt, Sharon
Publicado 2016

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States

por Stepanova, Maria, Clement, Stephen, Wong, Robert, Saab, Sammy, Ahmed, Aijaz, Younossi, Zobair M.
Publicado 2017